ODI Founder Professor Knut Kvernebo receives pre-seed grant from Novo Nordic

Oslo 2015-06-01

ODI Medical Founder Professor Knut Kvernebo at Oslo University Hospital has received a pre-seed grant of 500.000 DKK from The Novo Nordisk Foundation.

“The Novo Nordisk Foundation has very strict criteria for selecting its projects, and we won a grant in tough competition with many other innovators. Having the support in my concept from the Novo team means a great deal to me!” states a proud inventor and founder, Professor Knut Kvernebo.
ODI Medical
ODI Medical is developing technology for bedside measurement and quantification of circulatory failure based on assessment of microcirculation. Our concept, the Oxygen Delivery Index™, may be used for a wide range of clinical applications such as monitoring patients on mechanical heart and lung machines, evaluation of toxicity of chemotherapy, early detection of evolving sepsis; monitoring of chronic wounds, and mass screening of conditions such as Ebola, bird flu or endemic meningitis. ODI Medical is commercialising its concepts on the foundation of 30 years research from its founder, Professor Knut Kvernebo, from The Oslo University Hospital (OUS), Oslo, Norway.